Filing Flows › Health Care › Fresenius Medical Care AG (FMS)
Fresenius Medical Care AG (FMS) earnings and revenue breakdown
Latest: Q3 2026 · 6-K filed Nov 3, 2026 · Fresenius Medical Care AG (FMS) Q3 2026 earnings results →
Q3 2026 Revenue up 1% year over year to $9.9B · 2¢ of every $1 of revenue kept as net profit · operating margin 3.9%
Fresenius Medical Care AG made $9.9B in Q3 2026 (+1% Y/Y): 2 a), 14 $4.9B, Healthcare services $3.3B, Healthcare products $1.1B. Operating margin 3.9%, net earnings $160M. See where every dollar goes — costs, profit and cash — as a Sankey from the 6-K filed Nov 3, 2026.
Drawing the Sankey…
Open the interactive Sankey → click any line for what the company wrote about it, compare Y/Y and Q/Q, export as PNG or PDF
What changed this quarter
Revenue was €9.9B in Q3 2026, up 1% year over year. 2 a), 14 was the largest line at 50% of revenue. Healthcare services added €0.09B year over year (up 3%), 90% of the total change. Insurance contracts declined 11%.
Operating profit was €0.38B, a 3.9% margin (down 1.0 points year over year). Operating profit fell €0.09B even though revenue rose €0.10B versus a year earlier, so costs grew faster than sales. Total costs grew 2% against revenue growth of 1%. Net earnings were €0.16B, down 42% year over year. The effective tax rate was 25.7%.
Quarterly history
| Quarter | Form | Filed | Revenue | Y/Y | Op. margin | Net earnings | Op. cash flow |
|---|---|---|---|---|---|---|---|
| Q3 2026 | 6-K | Nov 3, 2026 | $9.9B | +1% | 3.9% | $160M | — |
Charts
Interactive views
The same charts as the app — open one to draw it.
💵Where each $1 goesinteractive
Loading the interactive chart…
🌏Named in Asian annual reportsinteractive
Loading the interactive chart…
🔄Rotation against the market and its industry (RRG)interactive
Loading the interactive chart…
🔍Earnings qualityinteractive
Loading the interactive chart…
⚖️Fair value by methodinteractive
Loading the interactive chart…
🔭Outlook & guidanceinteractive
Loading the interactive chart…
📈Investments: gains and what it boughtinteractive
Loading the interactive chart…
🏭Its industry’s money flow (input-output)interactive
Loading the interactive chart…
Customers and suppliers named in filings
Sells to
Fresenius Medical Care AG against its Services-Misc Health & Allied Services, NEC peers
The largest companies of the same SEC industry, each at its latest quarter. Revenue growth: +1% against the peers' median +5%. Operating margin: 3.9% against the peers' median 8.6%.
| Company | Quarter | Revenue | Y/Y | Op. margin |
|---|---|---|---|---|
| FMS Fresenius Medical Care AG | Q3 2026 | $11.4B | +1% | 3.9% |
| DVA Davita | Q3 2026 | $3.6B | +5% | 14.0% |
| AGL agilon health | Q3 2026 | $1.5B | +6% | 1.6% |
| PGNY Progyny | Q3 2026 | $341M | +9% | 10.3% |
| SHC Sotera Health | Q3 2026 | $325M | +4% | 25.8% |
| VMD Viemed Healthcare | Q3 2026 | $80.7M | +12% | 8.6% |
| PARK Park Dental Partners | Q2 2026 | $66.2M | +5% | 1.9% |
| CCEL Cryo Cell International | Q3 FY26 | $7.8M | 0% | 28.0% |
| MRAI Marpai | Q2 2026 | $4.2M | -10% | -82.4% |
Source: Fresenius Medical Care AG 6-K on SEC EDGAR · CIK 1333141 · Services-Misc Health & Allied Services, NEC
13F: who owns FMS and who is buying
More on FMS
History
Every quarter: Q3 2026 results